97 related articles for article (PubMed ID: 19651440)
1. Susceptibility of mantle cell lymphomas to reovirus oncolysis.
Alain T; Muzik H; Otsuka S; Chan S; Magliocco T; Diaz R; Forsyth PA; Morris D; Bebb G
Leuk Res; 2010 Jan; 34(1):100-8. PubMed ID: 19651440
[TBL] [Abstract][Full Text] [Related]
2. Reovirus and tumor oncolysis.
Kim M; Chung YH; Johnston RN
J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
[TBL] [Abstract][Full Text] [Related]
3. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.
Shmulevitz M; Marcato P; Lee PW
Oncogene; 2005 Nov; 24(52):7720-8. PubMed ID: 16299532
[TBL] [Abstract][Full Text] [Related]
4. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oncolytic reovirus against human breast cancer cells.
Hata Y; Etoh T; Inomata M; Shiraishi N; Nishizono A; Kitano S
Oncol Rep; 2008 Jun; 19(6):1395-8. PubMed ID: 18497942
[TBL] [Abstract][Full Text] [Related]
6. The effects of oncolytic reovirus in canine lymphoma cell lines.
Hwang CC; Umeki S; Igase M; Coffey M; Noguchi S; Okuda M; Mizuno T
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():61-73. PubMed ID: 25319493
[TBL] [Abstract][Full Text] [Related]
7. All reovirus subtypes show oncolytic potential in primary cells of human high-grade glioma.
Alloussi SH; Alkassar M; Urbschat S; Graf N; Gärtner B
Oncol Rep; 2011 Sep; 26(3):645-9. PubMed ID: 21637921
[TBL] [Abstract][Full Text] [Related]
8. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
Shmulevitz M; Lee PW
Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-based therapy for mantle cell lymphoma.
Munger CM; Vose JM; Joshi SS
Int J Oncol; 2006 Jun; 28(6):1337-43. PubMed ID: 16685434
[TBL] [Abstract][Full Text] [Related]
10. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression promotes reovirus therapy of colorectal liver metastases.
Smakman N; van der Bilt JD; van den Wollenberg DJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
Cancer Gene Ther; 2006 Aug; 13(8):815-8. PubMed ID: 16543920
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic viral therapy using reovirus.
Thirukkumaran C; Morris DG
Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
[TBL] [Abstract][Full Text] [Related]
13. Acquired resistance to reoviral oncolysis in Ras-transformed fibrosarcoma cells.
Kim M; Egan C; Alain T; Urbanski SJ; Lee PW; Forsyth PA; Johnston RN
Oncogene; 2007 Jun; 26(28):4124-34. PubMed ID: 17213803
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic viral therapy for human pancreatic cancer cells by reovirus.
Etoh T; Himeno Y; Matsumoto T; Aramaki M; Kawano K; Nishizono A; Kitano S
Clin Cancer Res; 2003 Mar; 9(3):1218-23. PubMed ID: 12631628
[TBL] [Abstract][Full Text] [Related]
15. The use of monoreassortants and reverse genetics to map reovirus lysis of a ras-transformed cell line.
Roner MR; Mutsoli C
J Virol Methods; 2007 Feb; 139(2):132-42. PubMed ID: 17049626
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
17. Reovirus oncolysis in human head and neck squamous carcinoma cells.
Ikeda Y; Nishimura G; Yanoma S; Kubota A; Furukawa M; Tsukuda M
Auris Nasus Larynx; 2004 Dec; 31(4):407-12. PubMed ID: 15571915
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Reoviral Cytolysis (I): Combination Therapeutics.
Mori Y; Nishikawa SG; Fratiloiu AR; Tsutsui M; Kataoka H; Joh T; Johnston RN
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515160
[TBL] [Abstract][Full Text] [Related]
19. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
20. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy.
Twigger K; Vidal L; White CL; De Bono JS; Bhide S; Coffey M; Thompson B; Vile RG; Heinemann L; Pandha HS; Errington F; Melcher AA; Harrington KJ
Clin Cancer Res; 2008 Feb; 14(3):912-23. PubMed ID: 18245555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]